MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235)

Market Cap	2.60B
Revenue (ttm)	367.79M
Net Income (ttm)	-67.17M
Shares Out	418.59M
EPS (ttm)	-0.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,800
Average Volume	67,560
Open	6.20
Previous Close	6.20
Day's Range	6.15 - 6.20
52-Week Range	3.12 - 6.92
Beta	0.41
RSI	54.82
Earnings Date	May 30, 2025

About HKG:2235

MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and sale of diabetes management, diabetes treatment, and diabetes monitoring medical devices to diabetes management in China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop artificial pancreas systems; blood glucose monitoring systems; Exactive Pro blood glucose, blood ketone, and uric acid monitoring system; and diabetes digital management...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 678
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2235

Financial Performance

In 2024, HKG:2235's revenue was 345.62 million, an increase of 36.48% compared to the previous year's 253.23 million. Losses were -63.12 million, -49.51% less than in 2023.

Financial numbers in CNY